Product logins

Find logins to all Clarivate products below.


Oregon & Washington | Winter | 2008 | Health Plan Analysis

Washington's individual health insurance market is growing, but medical cost trends have resulted in double-digit premium increases. As a result, the state's insurance commissioner is backing legislation to regulate rate increases for this segment of the market. Meanwhile, some Washington physician groups are urging their patients to bypass fee-for-service Medicare in favor of physician-owned Medicare Advantage plans. A chronic disease management program for Medicaid beneficiaries in Washington has netted strong financial returns in its final year. Finally, Regence – which operates Blue Cross and Blue Shield plans in both Oregon and Washington – has interesting results from a survey on consumers' online behavior as it relates to healthcare.

Related Market Access Reports

Report
Samaritan Health Services | Oregon | 2025 | Health Plan Profile
Health Plan Analysis reports feature a comprehensive look at the managed care market within each state, plus the District of Columbia and Puerto Rico. The product assesses payer/provider influence
Report
CareOregon | Oregon | 2025 | Health Plan Profile
Health Plan Analysis reports feature a comprehensive look at the managed care market within each state, plus the District of Columbia and Puerto Rico. The product assesses payer/provider influence
Report
PacificSource Health | Oregon | 2025 | Health Plan Profile
Health Plan Analysis reports feature a comprehensive look at the managed care market within each state, plus the District of Columbia and Puerto Rico. The product assesses payer/provider influence
Report
Washington, D.C. | MO Brief
Market Overview Briefs are Powerpoint slide presentations offering a condensed version of Market Overview reports.
Report
Washington, D.C. | Market Overview
Market Overview analyzes 87 metro area healthcare market dynamics, including top providers and payers. Market Overview includes MO Advanced Dashboard for segmenting and comparing markets. In 2023,